Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
European Journal of Neurology
|
September 17, 2024
Association of anti-calcitonin gene-related peptide with other monoclonal antibodies for different diseases: A multicenter, prospective, cohort study
Luigi Francesco Iannone, Marina Romozzi, Antonio Russo, et al.
Haematologica
|
November 30, 2019
Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction
Gijs Kooij, Claudio Derada Troletti, Alessandro Leuti, et al.
The Journal of Headache and Pain
|
July 3, 2026
Predictive factors of response to anti-CGRP pathway drugs in people with multiple sclerosis
Viviana Nociti, Simone Cesarano, Marina Romozzi, et al.
Therapeutic Advances in Neurological Disorders
|
December 25, 2025
Effectiveness and tolerability of lasmiditan in the acute treatment of migraine: a real-world, prospective, multicentric study (DART study)
Gloria Vaghi, Luigi Francesco Iannone, Michele Corrado, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
March 20, 2023
Validation of the Italian version of the Cluster Headache Impact Questionnaire (CHIQ)
Agnese Onofri, Luigi Francesco Iannone, Antonio Granato, et al.
Cephalalgia : an International Journal of Headache
|
June 26, 2026
SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study)
Claudia Altamura, Luigi Francesco Iannone, Flavia Lo Castro, et al.
Cephalalgia : an International Journal of Headache
|
March 25, 2026
The chronopharmacology of atogepant in migraine prevention: A real-world evaluation of influence of timing of administration on effectiveness and tolerability
Luigi Francesco Iannone, Gabriele Sebastianelli, Federico De Santis, et al.
Cephalalgia : an International Journal of Headache
|
February 13, 2026
Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study)
Luigi Francesco Iannone, Elisa Maria Piella, Danilo Antonio Montisano, et al.
The Journal of Headache and Pain
|
October 2, 2025
Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE)
Piero Barbanti, Giulia Fiorentini, Cecilia Camarda, et al.
Neurology
|
January 28, 2026
Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort
Edoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
European Journal of Neurology
|
September 17, 2024
Association of anti-calcitonin gene-related peptide with other monoclonal antibodies for different diseases: A multicenter, prospective, cohort study
Luigi Francesco Iannone, Marina Romozzi, Antonio Russo, et al.
Haematologica
|
November 30, 2019
Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction
Gijs Kooij, Claudio Derada Troletti, Alessandro Leuti, et al.
The Journal of Headache and Pain
|
July 3, 2026
Predictive factors of response to anti-CGRP pathway drugs in people with multiple sclerosis
Viviana Nociti, Simone Cesarano, Marina Romozzi, et al.
Therapeutic Advances in Neurological Disorders
|
December 25, 2025
Effectiveness and tolerability of lasmiditan in the acute treatment of migraine: a real-world, prospective, multicentric study (DART study)
Gloria Vaghi, Luigi Francesco Iannone, Michele Corrado, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
March 20, 2023
Validation of the Italian version of the Cluster Headache Impact Questionnaire (CHIQ)
Agnese Onofri, Luigi Francesco Iannone, Antonio Granato, et al.
Cephalalgia : an International Journal of Headache
|
June 26, 2026
SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study)
Claudia Altamura, Luigi Francesco Iannone, Flavia Lo Castro, et al.
Cephalalgia : an International Journal of Headache
|
March 25, 2026
The chronopharmacology of atogepant in migraine prevention: A real-world evaluation of influence of timing of administration on effectiveness and tolerability
Luigi Francesco Iannone, Gabriele Sebastianelli, Federico De Santis, et al.
Cephalalgia : an International Journal of Headache
|
February 13, 2026
Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study)
Luigi Francesco Iannone, Elisa Maria Piella, Danilo Antonio Montisano, et al.
The Journal of Headache and Pain
|
October 2, 2025
Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE)
Piero Barbanti, Giulia Fiorentini, Cecilia Camarda, et al.
Neurology
|
January 28, 2026
Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort
Edoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo, et al.
Page
of 9